primary osteoporosis
Conditions
Interventions
Experimental group:Bugushengsui granule
Control group:Calcitriol soft capsule
Sponsors
Wangjing Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. In accordance with the diagnosis of primary osteoporosis; 2. Both women and men, from 45 to 75 years old; 3. The participants don't use anti-osteoporosis medicine in half a year; 4. The patients sign informed consent voluntarily.
Exclusion criteria
Exclusion criteria: 1. metabolic bone disease around the body; 2. Fracture by traumatic injuries in two years; 3. Chronic diseases affecting bone metabolism, including diabetes, rheumatoid arthritis, hyperparathyroidism, hyperthyroidism and other chronic diseases that require long-term treatment; 4. Severe heart and brain vessels diseases; 5. Liver and kidney dysfunction; 6. Chronic gastrointestinal diseases; 7. Acute or chronic infection in the near future; 8. Strenuous exercise in two or three days; 9. Serious organic disease, mental and nervous system diseases, and active osteoarthropathy; 10. The patients who have taken estrogen and calcitonin, or fluoride, bisphosphonates,adrenocortical hormone in one year.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| procollagen 1 N-terminal propeptid;cross linked C-telopeptide of type 1 collagen;bone mineral density; | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS score;TCM symdrome score; | — |
Countries
China
Contacts
Public ContactXu Wei
Wangjing Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed